Avid Bioservices Inc (CDMO)

[pphmtoolong]

Sell now, buy back later? Might work, might not. Timing the market is considered too difficult for professional money managers. How much more difficult do you think it is to time Peregrine' shares?

What we do know is that Peregrine's Bavituximab is closer to establishing it's value than it was last year or five years ago. Whether that value is a lot or a little will be clear in days to months.

It is probably true that the wait is months. The Sunrise first or second look-ins around mid-2016 will provide huge data points.

The problem with waiting for that is a BP may decide to force the issue before definitive data comes in. No way to know how likely this is. The Bavi preclinical case for a BP buy is already established. The early clinical data of Bavi and the SOC is very promising. The early phase bavi-yervoy trial is well along. The MSK research has just started; no idea how fast that might proceed.

Conclusion, you might sell and put your money in a money market at sub 1 percent, and buy in when the you like. Or you can hold on or add assuring yourself of a seat on the plane if it should take off ahead of schedule.

Exciting times.

GLTA, Especially Bavi-arm Sunrise Patients,

Paul